Ozempic Linked With Lower Dementia Risk, Nicotine Use, British Study Finds (Reuters) - Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems ...

This is just one of a growing list of diseases and conditions Ozempic has been ... Two new studies out today have linked the use of GLP-1 drugs to a lower dementia risk. New Africa ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Published in Alzheimer’s & Dementia on Thursday ... ingredient in popular weight loss drugs like Ozempic and Wegovy — may be linked to lower risks of Alzheimer's disease in people with ...

New research suggests that the diabetes drug and popular weight loss treatment semaglutide, sold as Ozempic and Wegovy, is linked with a significantly lower risk of dementia — possibly adding to ...

Semaglutide, the main active ingredient in Ozempic, is linked to a lower risk of cognitive decline ... develop cognitive issues that could include dementia. “Because this study was observational ...

Well, this is just one study, so it’s hard to say for sure that Ozempic will lower your risk for dementia. But a 2024 study published in the journal Alzheimer’s & Dementia also linked these ...

July 12 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab popular diabetes treatment Ozempic could be tied ... drugs may be associated with a lower risk of dementia and can help reduce nicotine ...

Type 2 diabetes is a risk factor for dementia ... lower risk compared to older GLP-1 drugs including liraglutide — a finding ...

According to a study published on October 24, 2024, in the journal Alzheimer’s & Dementia, the type 2 diabetes and weight loss drug semaglutide (sold under the brand names Ozempic, Wegovy ...